UNSPSC 51132000: Hemorrheologic agents

This classification denotes drugs that improve blood flow by various mechanisms, such as increasing erythrocyte and leukocyte flexibility.

UNSPSC 51132000 Hemorrheologic agents is a Class code under which state and local governments procure chemical supplies and pharmaceutical products for water treatment, healthcare, and facility operations. Recent solicitation activity shows two distinct procurement streams: municipal water utilities sourcing specific treatment chemicals like sodium bisulfite, and multistate cooperative purchasing alliances aggregating generic pharmaceuticals and over-the-counter products for distribution across state and local healthcare and detention facilities. The issuing bodies include municipal water pollution control departments and state procurement offices administering cooperative purchasing vehicles that serve multiple participating jurisdictions.

The code shows recent activity centered in the Upper Midwest and Connecticut. The City of Meriden, Connecticut issued IFB B027-15 for sodium bisulfite chemical supply to its Water Pollution Control Facility with a response deadline of July 29, 2026, requiring bidders to carry $1,000,000–$2,000,000 in general liability coverage and performance bonding. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products sourced through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC—with products to become effective July 1, 2026. The MMCAP procurement emphasizes price competitiveness (weighted at 75 percent of evaluation), requires cGMP and DSCSA compliance, and applies a 3 percent administrative fee on all purchases with performance penalties ranging from $200 to $1,500 per violation.